{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:57:16Z","timestamp":1785895036632,"version":"3.56.0"},"reference-count":61,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2025,4,3]]},"DOI":"10.1080\/03007995.2025.2466726","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:34:04Z","timestamp":1740022444000},"page":"721-732","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adults"],"prefix":"10.1080","volume":"41","author":[{"given":"Ekkehard","family":"Beck","sequence":"first","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Georgieva","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jhih","family":"Wang","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Gomez-Lievano","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjue","family":"Wang","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Gao","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Kopel","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bausch-Jurken","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Patterson-Lomba","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Mu","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wu","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Van de Velde","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"Centers for Disease Control and Prevention. Respiratory Virus Hospitalization Surveillance Network (RESP-NET); 2024 [cited 2024 October 28]. Available from: https:\/\/www.cdc.gov\/resp-net\/dashboard\/."},{"key":"e_1_3_5_3_1","unstructured":"Centers for Disease Control and Prevention. Adult Vaccination Coverage and Intent; 2024 [cited 2024 October 28]. Available from: https:\/\/www.cdc.gov\/covidvaxview\/weekly-dashboard\/adult-vaccination-coverage.html."},{"key":"e_1_3_5_4_1","unstructured":"Centers for Disease Control and Prevention. Flu Vaccination Coverage United States 2023\u201324\u2014Influenza Season; 2024 [cited 2024 October 28]. Available from: https:\/\/www.cdc.gov\/fluvaxview\/coverage-by-season\/2023-2024.html."},{"key":"e_1_3_5_5_1","unstructured":"ClinicalTrials.gov. A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants \u226512 Years of Age to Prevent COVID-19 (NextCOVE); 2024 [cited 2024 October 28]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05815498."},{"key":"e_1_3_5_6_1","unstructured":"Moderna Inc. Moderna Investor Day; 2024 [cited 2024 October 28]. Available from: https:\/\/investors.modernatx.com\/events-and-presentations\/Investor-Days\/default.aspx."},{"key":"e_1_3_5_7_1","unstructured":"Rizkalla B.\u00a0Overview of Moderna\u2019s\u00a0investigational next generation COVID-19 vaccine mRNA-1283 in individuals \u226512 years of age ACIP; 2025\u00a0[cited 2025\u00a0April 25]. Available\u00a0from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-04-15-16\/02-Rizkalla-COVID-508.pdf"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae695"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.1640"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00692-2"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7153a1"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41537-7"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad288"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.07.014"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111711"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01272-z"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00936-z"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101107"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1204831"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086754"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-069989"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7223"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5764"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.06.011"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.014"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101331"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1994858"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2270039"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(97)00049-8"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/jmahp12020006"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.05.015"},{"key":"e_1_3_5_34_1","unstructured":"Philippo D Ades T Dias S et\u00a0al. NICE DSU technical support document 18: methods for population-adjusted indirect comparisons in submissions to NICE; 2016 [cited 2024 October 28]. Available from: https:\/\/research-information.bris.ac.uk\/ws\/portalfiles\/portal\/94868463\/Population_adjustment_TSD_FINAL.pdf."},{"key":"e_1_3_5_35_1","unstructured":"Canadian Agency for Drugs and Technologies in Health. Indirect evidence: indirect treatment comparisons in meta-analysis; 2009 [cited 2024 October 28]. Available from: https:\/\/www.cda-amc.ca\/sites\/default\/files\/pdf\/H0462_itc_tr_e.pdf."},{"key":"e_1_3_5_36_1","unstructured":"Australian Government Department of Health. Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (PBAC). Version 5.0; 2016 [cited 2024 October 28]. Available from: https:\/\/pbac.pbs.gov.au\/content\/information\/files\/pbac-guidelines-version-5.pdf."},{"key":"e_1_3_5_37_1","unstructured":"Johns Hopkins Bloomberg School of Public Health. International vaccine access center; 2024 [cited 2024 October 28]. Available from: https:\/\/publichealth.jhu.edu\/ivac."},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110345"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107456"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200674"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2214916"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020118"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.08.1941"},{"key":"e_1_3_5_44_1","unstructured":"International Vaccine Access Center. COVID vaccines study explorer; 2024 [cited 2024 October 28]. Available from: https:\/\/view-hub.org\/vaccine\/covid\/."},{"key":"e_1_3_5_45_1","unstructured":"Johns Hopkins Bloomberg School of Public Health. About IVAC; 2024 [cited 2024 October 28]. Available from: https:\/\/publichealth.jhu.edu\/ivac\/about-ivac."},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.10.072"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7145a2"},{"key":"e_1_3_5_48_1","unstructured":"Centers for Disease Control and Prevention. Symptoms of COVID-19; 2024 [cited 2024 October 28]. Available from: https:\/\/www.cdc.gov\/covid\/signs-symptoms\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html."},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.36469\/jheor.2023.87538"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315727"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03117-7"},{"key":"e_1_3_5_52_1","unstructured":"ACIP. ACIP Evidence to Recommendations (EtR) for use of bivalent COVID-19 vaccine booster doses under an emergency use authorization; 2024 [cited 2024 October 28]. Available from: https:\/\/www.cdc.gov\/acip\/evidence-to-recommendations\/covid-19-bivalent-booster-etr.html."},{"key":"e_1_3_5_53_1","unstructured":"Pfizer and BioNTech Granted FDA emergency use authorization of omicron BA.4\/BA.5-adapted bivalent COVID-19 vaccine booster for ages 12 years and older; 2022 [cited 2024 October 28]. Available from: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-granted-fda-emergency-use-authorization."},{"key":"e_1_3_5_54_1","unstructured":"FDA. EUA amendment review memorandum; 2022."},{"key":"e_1_3_5_55_1","unstructured":"ACIP. Grading of Recommendations Assessment Development and Evaluation (GRADE): Updated COVID-19 vaccine (2024\u20132025 Formulation); 2024 [cited 2024 October 28]. Available from: https:\/\/www.cdc.gov\/acip\/grade\/covid-19-2024-2025-6-months-and-older.html."},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7337e2"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.5888\/pcd17.200130"},{"key":"e_1_3_5_58_1","article-title":"Relative vaccine efficacy of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine versus mRNA-1273: subgroup analyses","author":"Chalkias S","year":"2025","unstructured":"Chalkias S, Grassi C, Dennis P, et\u00a0al. Relative vaccine efficacy of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine versus mRNA-1273: subgroup analyses. Eur Soc Clin Microbiol Infect Dis. (ECCMID) 2025 accepted abstract (Oral presentation number O0341).","journal-title":"Eur Soc Clin Microbiol Infect Dis"},{"key":"e_1_3_5_59_1","unstructured":"Centers for Disease Control and Prevention. Background for CDC\u2019s updated respiratory virus guidance; 2024 [cited 2024 October 28]. Available from: https:\/\/www.cdc.gov\/respiratory-viruses\/guidance\/background.html."},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06025-4"},{"key":"e_1_3_5_61_1","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines in the United States; 2024. [cited October 31]. Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7242e1"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2025.2466726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T15:02:42Z","timestamp":1753282962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2025.2466726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,3]]}},"alternative-id":["10.1080\/03007995.2025.2466726"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2025.2466726","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}